Tapewire

Nasdaq · USD

GPCR

Structure Therapeutics Inc.

Export transactions ↓
Tapewire entity
1222
SEC CIK
0001888886
Parsed reports
115

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 23, 2025 Filed Jun 25, 2025 21:45 UTC GrantShare Option (right to buy) · Derivative 51,804 $0.00 Strike: $7.37 $0.00
Disclosure

SEC source: 0001415889-25-018213 · form4-06252025_050601.xml · derivative · entry 1

WELCH DANIEL G · CIK 0001206199 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,804

Underlying: Ordinary Shares · 51,804 shares

Expires 2035-06-22

F1 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's American Depositary Shares ("ADSs").

F2 · derivative.exercise_date: The shares vest in equal monthly installments over the 12 months following June 23, 2025, provided that the grant will in any case be fully vested on the date immediately prior to the date of the Issuer's 2026 annual shareholder meeting,

F3 · derivative.underlying_shares: The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer.

Read SEC document
June 23, 2025 Filed Jun 25, 2025 21:45 UTC
LOVE TED WDirector
GrantShare Option (right to buy) · Derivative 51,804 $0.00 Strike: $7.37 $0.00
Disclosure

SEC source: 0001415889-25-018217 · form4-06252025_050609.xml · derivative · entry 1

LOVE TED W · CIK 0001188919 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,804

Underlying: Ordinary Shares · 51,804 shares

Expires 2035-06-22

F1 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's American Depositary Shares ("ADSs").

F2 · derivative.exercise_date: The shares vest in equal monthly installments over the 12 months following June 23, 2025, provided that the grant will in any case be fully vested on the date immediately prior to the date of the Issuer's 2026 annual shareholder meeting,

F3 · derivative.underlying_shares: The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer.

Read SEC document
June 23, 2025 Filed Jun 25, 2025 21:45 UTC GrantShare Option (right to buy) · Derivative 51,804 $0.00 Strike: $7.37 $0.00
Disclosure

SEC source: 0001415889-25-018215 · form4-06252025_050605.xml · derivative · entry 1

DOBMEIER ERIC · CIK 0001202785 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,804

Underlying: Ordinary Shares · 51,804 shares

Expires 2035-06-22

F1 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's American Depositary Shares ("ADSs").

F2 · derivative.exercise_date: The shares vest in equal monthly installments over the 12 months following June 23, 2025, provided that the grant will in any case be fully vested on the date immediately prior to the date of the Issuer's 2026 annual shareholder meeting,

F3 · derivative.underlying_shares: The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer.

Read SEC document
June 23, 2025 Filed Jun 25, 2025 21:45 UTC GrantShare Option (right to buy) · Derivative 51,804 $0.00 Strike: $7.37 $0.00
Disclosure

SEC source: 0001415889-25-018214 · form4-06252025_050603.xml · derivative · entry 1

TETLOW SHARON · CIK 0001328565 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,804

Underlying: Ordinary Shares · 51,804 shares

Expires 2035-06-22

F1 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's American Depositary Shares ("ADSs").

F2 · derivative.exercise_date: The shares vest in equal monthly installments over the 12 months following June 23, 2025, provided that the grant will in any case be fully vested on the date immediately prior to the date of the Issuer's 2026 annual shareholder meeting,

F3 · derivative.underlying_shares: The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer.

Read SEC document
June 23, 2025 Filed Jun 25, 2025 21:45 UTC GrantShare Option (right to buy) · Derivative 42,833 $0.00 Strike: $7.37 $0.00
Disclosure

SEC source: 0001415889-25-018218 · form4-06252025_050611.xml · derivative · entry 1

Russell Angus C. · CIK 0001534002 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,833

Underlying: Ordinary Shares · 42,833 shares

Expires 2035-06-22

F1 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's American Depositary Shares ("ADSs").

F2 · derivative.exercise_date: The shares vest in equal monthly installments over the 12 months following June 23, 2025, provided that the grant will in any case be fully vested on the date immediately prior to the date of the Issuer's 2026 annual shareholder meeting,

F3 · derivative.underlying_shares: The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer.

Read SEC document
June 23, 2025 Filed Jun 25, 2025 21:45 UTC GrantShare Option (right to buy) · Derivative 51,804 $0.00 Strike: $7.37 $0.00
Disclosure

SEC source: 0001415889-25-018216 · form4-06252025_050607.xml · derivative · entry 1

Waldstreicher Joanne · CIK 0001962413 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,804

Underlying: Ordinary Shares · 51,804 shares

Expires 2035-06-22

F1 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's American Depositary Shares ("ADSs").

F2 · derivative.exercise_date: The shares vest in equal monthly installments over the 12 months following June 23, 2025, provided that the grant will in any case be fully vested on the date immediately prior to the date of the Issuer's 2026 annual shareholder meeting,

F3 · derivative.underlying_shares: The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer.

Read SEC document
May 21, 2025 Filed Jul 3, 2025 17:15 UTC
Coll Crespo BlasCHIEF MEDICAL OFFICER
GrantAmerican Depositary Shares · Derivative 429 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-019354 · form4-07032025_050709.xml · derivative · entry 4

Coll Crespo Blas · CIK 0002037144 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,157

Underlying: Ordinary Shares · 1,287 shares

Expires not disclosed

F4 · derivative.exercise_price: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date.

F5 · kind: Voluntary reporting of the acquisition of 429 ADSs by the Reporting Person on May 21, 2025 pursuant to the Issuer's Employee Share Purchase Plan.

F4 · derivative.exercise_date: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date.

F4 · derivative.expiration_date: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date.

F1 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

Read SEC document
May 21, 2025 Filed Jul 3, 2025 21:15 UTC
Stevens Raymond CDirector · CHIEF EXECUTIVE OFFICER
GrantAmerican Depositary Shares · Derivative 1,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-019350 · form4-07032025_050702.xml · derivative · entry 5

Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,000

Underlying: Ordinary Shares · 3,000 shares

Expires not disclosed

F5 · derivative.exercise_price: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date.

F6 · kind: Voluntary reporting of the acquisition of 1,000 ADSs by the Reporting Person on May 21, 2025 pursuant to the Issuer's Employee Share Purchase Plan.

F5 · derivative.exercise_date: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date.

F5 · derivative.expiration_date: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date.

F1 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

Read SEC document
May 21, 2025 Filed Jul 3, 2025 21:15 UTC
Yoon JunCHIEF FINANCIAL OFFICER
GrantAmerican Depositary Shares · Derivative 831 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-019351 · form4-07032025_050704.xml · derivative · entry 5

Yoon Jun · CIK 0001962414 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,946

Underlying: Ordinary Shares · 2,963 shares

Expires not disclosed

F5 · derivative.exercise_price: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date.

F5 · derivative.exercise_date: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date.

F5 · derivative.expiration_date: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date.

F1 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

Read SEC document
May 20, 2025 Filed Mar 5, 2026 18:20 UTC
Hall AshleyChief Development Officer
GrantAmerican Depositary Shares · Derivative 225 $0.00 $0.00
Disclosure

SEC source: 0001801842-26-000002 · form4-03052026_060304.xml · derivative · entry 2

Hall Ashley · CIK 0001801842 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 225

Underlying: Ordinary Shares · 675 shares

Expires not disclosed

F3 · derivative.exercise_price: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date.

F4 · kind: Voluntary reporting of the acquisition of 225 ADSs by the Reporting Person on May 20, 2025 pursuant to the Issuer's Employee Share Purchase Plan.

F3 · derivative.exercise_date: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date.

F3 · derivative.expiration_date: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date.

F1 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

Read SEC document
March 15, 2025 Filed Mar 18, 2025 20:45 UTC
Coll Crespo BlasChief Medical Officer
GrantEmployee Stock Option (right to buy) · Derivative 284,241 $0.00 Strike: $7.02 $0.00
Disclosure

SEC source: 0001415889-25-008555 · form4-03182025_080313.xml · derivative · entry 2

Coll Crespo Blas · CIK 0002037144 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 284,241

Underlying: Ordinary Shares · 284,241 shares

Expires 2035-03-14

F3 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs.

F4 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest March 1, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date.

F1 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

Read SEC document
March 15, 2025 Filed Mar 18, 2025 20:45 UTC
Coll Crespo BlasChief Medical Officer
GrantOrdinary Shares 116,988 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-008555 · form4-03182025_080313.xml · nonDerivative · entry 1

Coll Crespo Blas · CIK 0002037144 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 219,588

F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

F2 · kind: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one Ordinary Share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2025, subject to Reporting Person's continued service on such dates.

Read SEC document
March 15, 2025 Filed Mar 18, 2025 20:45 UTC
Hall AshleyChief Development Officer
GrantEmployee Stock Option (right to buy) · Derivative 124,032 $0.00 Strike: $7.02 $0.00
Disclosure

SEC source: 0001415889-25-008554 · form4-03182025_080311.xml · derivative · entry 2

Hall Ashley · CIK 0001801842 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 124,032

Underlying: Ordinary Shares · 124,032 shares

Expires 2035-03-15

F3 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs.

F4 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest March 1, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date.

F1 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

Read SEC document
March 15, 2025 Filed Mar 18, 2025 20:45 UTC
Hall AshleyChief Development Officer
GrantOrdinary Shares 51,048 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-008554 · form4-03182025_080311.xml · nonDerivative · entry 1

Hall Ashley · CIK 0001801842 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 118,338

F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

F2 · kind: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one ordinary share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2025, subject to Reporting Person's continued service on such dates.

Read SEC document
March 15, 2025 Filed Mar 19, 2025 00:45 UTC
Stevens Raymond CDirector · CHIEF EXECUTIVE OFFICER
GrantEmployee Stock Option (right to buy) · Derivative 826,890 $0.00 Strike: $7.02 $0.00
Disclosure

SEC source: 0001415889-25-008550 · form4-03182025_080301.xml · derivative · entry 3

Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 826,890

Underlying: Ordinary Shares · 826,890 shares

Expires 2035-03-14

F4 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs.

F5 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest March 1, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date.

F1 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

Read SEC document
March 15, 2025 Filed Mar 19, 2025 00:45 UTC
Stevens Raymond CDirector · CHIEF EXECUTIVE OFFICER
GrantOrdinary Shares 340,332 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-008550 · form4-03182025_080301.xml · nonDerivative · entry 1

Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,133,678

F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

F2 · kind: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one Ordinary Share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2025, subject to Reporting Person's continued service on such dates.

Read SEC document
March 15, 2025 Filed Mar 19, 2025 00:45 UTC
Ma YingliCHIEF TECHNOLOGY OFFICER
GrantEmployee Stock Option (right to buy) · Derivative 155,040 $0.00 Strike: $7.02 $0.00
Disclosure

SEC source: 0001415889-25-008553 · form4-03182025_080308.xml · derivative · entry 2

Ma Yingli · CIK 0001963664 · CHIEF TECHNOLOGY OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 155,040

Underlying: Ordinary Shares · 155,040 shares

Expires 2035-03-15

F3 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs.

F4 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest March 1, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date.

F1 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

Read SEC document
March 15, 2025 Filed Mar 19, 2025 00:45 UTC
Ma YingliCHIEF TECHNOLOGY OFFICER
GrantOrdinary Shares 63,810 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-008553 · form4-03182025_080308.xml · nonDerivative · entry 1

Ma Yingli · CIK 0001963664 · CHIEF TECHNOLOGY OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,539

F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

F2 · kind: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one ordinary share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2025, subject to Reporting Person's continued service on such dates.

Read SEC document
March 15, 2025 Filed Mar 19, 2025 00:45 UTC
Lin XichenCHIEF SCIENTIFIC OFFICER
GrantEmployee Stock Option (right to buy) · Derivative 196,386 $0.00 Strike: $7.02 $0.00
Disclosure

SEC source: 0001415889-25-008552 · form4-03182025_080306.xml · derivative · entry 2

Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 196,386

Underlying: Ordinary Shares · 196,386 shares

Expires 2035-03-15

F3 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs.

F4 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest March 1, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date.

F1 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

Read SEC document
March 15, 2025 Filed Mar 19, 2025 00:45 UTC
Lin XichenCHIEF SCIENTIFIC OFFICER
GrantOrdinary Shares 80,829 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-008552 · form4-03182025_080306.xml · nonDerivative · entry 1

Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 166,536

F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

F2 · kind: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one ordinary share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2025, subject to Reporting Person's continued service on such dates.

Read SEC document
March 15, 2025 Filed Mar 19, 2025 00:45 UTC
Yoon JunCHIEF FINANCIAL OFFICER
GrantEmployee Stock Option (right to buy) · Derivative 413,445 $0.00 Strike: $7.02 $0.00
Disclosure

SEC source: 0001415889-25-008551 · form4-03182025_080303.xml · derivative · entry 3

Yoon Jun · CIK 0001962414 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 413,445

Underlying: Ordinary Shares · 413,445 shares

Expires 2035-03-14

F4 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs.

F5 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest March 1, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date.

F1 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

Read SEC document
March 15, 2025 Filed Mar 19, 2025 00:45 UTC
Yoon JunCHIEF FINANCIAL OFFICER
GrantOrdinary Shares 170,166 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-008551 · form4-03182025_080303.xml · nonDerivative · entry 1

Yoon Jun · CIK 0001962414 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,293,299

F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

F2 · kind: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one Ordinary Share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2025, subject to Reporting Person's continued service on such dates.

Read SEC document
March 01, 2025 Filed Jul 3, 2025 17:15 UTC
Coll Crespo BlasCHIEF MEDICAL OFFICER
Tax withholdingOrdinary Shares 1,233 $7.92 $9,761.17
Disclosure

SEC source: 0001415889-25-019354 · form4-07032025_050709.xml · nonDerivative · entry 1

Coll Crespo Blas · CIK 0002037144 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 218,355

F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

F2 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award.

Read SEC document
March 01, 2025 Filed Jul 3, 2025 21:15 UTC
Stevens Raymond CDirector · CHIEF EXECUTIVE OFFICER
Tax withholdingOrdinary Shares 12,495 $7.92 $98,917.92
Disclosure

SEC source: 0001415889-25-019350 · form4-07032025_050702.xml · nonDerivative · entry 1

Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,121,183

F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

F2 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award.

Read SEC document
March 01, 2025 Filed Jul 3, 2025 21:15 UTC
Ma YingliCHIEF TECHNOLOGY OFFICER
Tax withholdingOrdinary Shares 1,824 $7.92 $14,439.88
Disclosure

SEC source: 0001415889-25-019353 · form4-07032025_050708.xml · nonDerivative · entry 1

Ma Yingli · CIK 0001963664 · CHIEF TECHNOLOGY OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 98,715

F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

F2 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award.

Read SEC document
March 01, 2025 Filed Jul 3, 2025 21:15 UTC
Lin XichenCHIEF SCIENTIFIC OFFICER
Tax withholdingOrdinary Shares 6,441 $7.92 $50,990.82
Disclosure

SEC source: 0001415889-25-019352 · form4-07032025_050706.xml · nonDerivative · entry 1

Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 160,095

F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

F2 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award.

Read SEC document
March 01, 2025 Filed Jul 3, 2025 21:15 UTC
Yoon JunCHIEF FINANCIAL OFFICER
Tax withholdingOrdinary Shares 5,940 $7.92 $47,024.60
Disclosure

SEC source: 0001415889-25-019351 · form4-07032025_050704.xml · nonDerivative · entry 1

Yoon Jun · CIK 0001962414 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,287,359

F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

F2 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award.

Read SEC document
February 06, 2025 Filed Feb 10, 2025 13:36 UTC
FMR LLC10% owner · See Remark 1
SaleAmerican Depositary Shares · Derivative 41 $30.54 $1,252.14
Disclosure

SEC source: 0000950170-25-016705 · ownership.xml · derivative · entry 4

FMR LLC · CIK 0000315066 · 10% owner · See Remark 1

10b5-1 filing: No plan indicated

Ownership: Indirect · FIMM, LLC

Disclosed balance after: 0

Underlying: Ordinary Shares · 123 shares

Expires not disclosed

F1 · derivative.exercise_price: Reported securities are American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. Any one American Depositary Share may be converted into three Ordinary Shares, and any three Ordinary Shares into one American Depositary Share, at any time at the election of the holder upon notice.

F1 · derivative.exercise_date: Reported securities are American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. Any one American Depositary Share may be converted into three Ordinary Shares, and any three Ordinary Shares into one American Depositary Share, at any time at the election of the holder upon notice.

F1 · derivative.expiration_date: Reported securities are American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. Any one American Depositary Share may be converted into three Ordinary Shares, and any three Ordinary Shares into one American Depositary Share, at any time at the election of the holder upon notice.

Read SEC document
November 20, 2024 Filed Mar 18, 2025 20:45 UTC
Coll Crespo BlasChief Medical Officer
GrantAmerican Depositary Shares · Derivative 363 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-008555 · form4-03182025_080313.xml · derivative · entry 3

Coll Crespo Blas · CIK 0002037144 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 728

Underlying: Ordinary Shares · 1,089 shares

Expires not disclosed

F5 · derivative.exercise_price: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date.

F6 · kind: Voluntary reporting of the acquisition of 363 ADSs by the Reporting Person on Novembery 20, 2024 pursuant to the Issuer's Employee Share Purchase Plan.

F5 · derivative.exercise_date: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date.

F5 · derivative.expiration_date: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date.

F1 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

Read SEC document
November 20, 2024 Filed Mar 19, 2025 00:45 UTC
Yoon JunCHIEF FINANCIAL OFFICER
GrantAmerican Depositary Shares · Derivative 821 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-008551 · form4-03182025_080303.xml · derivative · entry 5

Yoon Jun · CIK 0001962414 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,115

Underlying: Ordinary Shares · 2,463 shares

Expires not disclosed

F6 · derivative.exercise_price: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date.

F8 · kind: Voluntary reporting of the acquisition of 821 ADSs by the Reporting Person on Novembery 20, 2024 pursuant to the Issuer's Employee Share Purchase Plan.

F6 · derivative.exercise_date: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date.

F6 · derivative.expiration_date: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date.

F1 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

Read SEC document
September 18, 2024 Filed Sep 20, 2024 17:42 UTC
Coll Crespo BlasChief Medical Officer
GrantShare option (right to buy) · Derivative 111,000 $0.00 Strike: $12.75 $0.00
Disclosure

SEC source: 0001415889-24-023791 · form4-09202024_090935.xml · derivative · entry 2

Coll Crespo Blas · CIK 0002037144 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 111,000

Underlying: Ordinary Shares · 111,000 shares

Expires 2034-09-17

F3 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs.

F4 · derivative.exercise_date: One-fourth of the shares vest on the first anniversary of September 18, 2024, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter.

F1 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

Read SEC document
September 18, 2024 Filed Sep 20, 2024 17:42 UTC
Coll Crespo BlasChief Medical Officer
GrantOrdinary Shares 90,600 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-023791 · form4-09202024_090935.xml · nonDerivative · entry 1

Coll Crespo Blas · CIK 0002037144 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 102,600

F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

F2 · shares: Represents restricted stock unit award granted under the Issuer's 2023 Equity Incentive Plan.

Read SEC document
September 18, 2024 Filed Sep 20, 2024 17:47 UTC
Hall AshleyChief Development Officer
GrantShare option (right to buy) · Derivative 82,890 $0.00 Strike: $12.75 $0.00
Disclosure

SEC source: 0001415889-24-023794 · form4-09202024_090932.xml · derivative · entry 2

Hall Ashley · CIK 0001801842 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,890

Underlying: Ordinary Shares · 82,890 shares

Expires 2034-09-17

F3 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs.

F4 · derivative.exercise_date: One-fourth of the shares vest on the first anniversary of September 18, 2024, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter.

F1 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

Read SEC document
September 18, 2024 Filed Sep 20, 2024 17:47 UTC
Hall AshleyChief Development Officer
GrantOrdinary Shares 67,290 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-023794 · form4-09202024_090932.xml · nonDerivative · entry 1

Hall Ashley · CIK 0001801842 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,290

F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

F2 · shares: Represents restricted stock unit award granted under the Issuer's 2023 Equity Incentive Plan.

Read SEC document
August 26, 2024 Filed Aug 28, 2024 20:37 UTC GrantShare option (right to buy) · Derivative 75,000 $0.00 Strike: $13.53 $0.00
Disclosure

SEC source: 0001415889-24-022457 · form4-08282024_080826.xml · derivative · entry 1

Russell Angus C. · CIK 0001534002 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Ordinary Shares · 75,000 shares

Expires 2034-08-25

F1 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's American Depositary Shares ("ADSs").

F2 · derivative.exercise_date: The shares vest in equal monthly installments over a three-year period such that the option is fully vested on the third anniversary of August 26, 2024.

F3 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer.

Read SEC document
June 25, 2024 Filed Jun 27, 2024 20:15 UTC GrantShare Option (right to buy) · Derivative 37,500 $0.00 Strike: $13.32 $0.00
Disclosure

SEC source: 0001415889-24-018324 · form4-06272024_040601.xml · derivative · entry 1

WELCH DANIEL G · CIK 0001206199 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Ordinary Shares · 37,500 shares

Expires 2034-06-24

F1 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's American Depositary Shares ("ADSs").

F2 · derivative.exercise_date: The shares vest in equal monthly installments over the 12 months following June 25, 2024.

F3 · derivative.underlying_shares: The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer.

Read SEC document
June 25, 2024 Filed Jun 27, 2024 20:15 UTC
LOVE TED WDirector
GrantShare Option (right to buy) · Derivative 33,595 $0.00 Strike: $13.32 $0.00
Disclosure

SEC source: 0001415889-24-018328 · form4-06272024_040609.xml · derivative · entry 1

LOVE TED W · CIK 0001188919 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,595

Underlying: Ordinary Shares · 33,595 shares

Expires 2034-06-24

F1 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's American Depositary Shares ("ADSs").

F2 · derivative.exercise_date: The shares vest in equal monthly installments over the 12 months following June 25, 2024.

F3 · derivative.underlying_shares: The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer.

Read SEC document
June 25, 2024 Filed Jun 27, 2024 20:15 UTC GrantShare Option (right to buy) · Derivative 37,500 $0.00 Strike: $13.32 $0.00
Disclosure

SEC source: 0001415889-24-018326 · form4-06272024_040605.xml · derivative · entry 1

DOBMEIER ERIC · CIK 0001202785 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Ordinary Shares · 37,500 shares

Expires 2034-06-24

F1 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's American Depositary Shares ("ADSs").

F2 · derivative.exercise_date: The shares vest in equal monthly installments over the 12 months following June 25, 2024.

F3 · derivative.underlying_shares: The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer.

Read SEC document
June 25, 2024 Filed Jun 27, 2024 20:15 UTC GrantShare Option (right to buy) · Derivative 37,500 $0.00 Strike: $13.32 $0.00
Disclosure

SEC source: 0001415889-24-018325 · form4-06272024_040603.xml · derivative · entry 1

TETLOW SHARON · CIK 0001328565 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Ordinary Shares · 37,500 shares

Expires 2034-06-24

F1 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's American Depositary Shares ("ADSs").

F2 · derivative.exercise_date: The shares vest in equal monthly installments over the 12 months following June 25, 2024.

F3 · derivative.underlying_shares: The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer.

Read SEC document
June 25, 2024 Filed Jun 27, 2024 20:15 UTC GrantShare Option (right to buy) · Derivative 37,500 $0.00 Strike: $13.32 $0.00
Disclosure

SEC source: 0001415889-24-018327 · form4-06272024_040607.xml · derivative · entry 1

Waldstreicher Joanne · CIK 0001962413 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Ordinary Shares · 37,500 shares

Expires 2034-06-24

F1 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's American Depositary Shares ("ADSs").

F2 · derivative.exercise_date: The shares vest in equal monthly installments over the 12 months following June 25, 2024.

F3 · derivative.underlying_shares: The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer.

Read SEC document
June 12, 2024 Filed Jun 15, 2024 00:19 UTC
Stevens Raymond CDirector · CHIEF EXECUTIVE OFFICER
Exercise / conversionShare Option (right to buy) · Derivative 50,001 $0.00 Strike: $0.48 $0.00
Disclosure

SEC source: 0001415889-24-017040 · form4-06152024_120647.xml · derivative · entry 5

Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 488,766

Underlying: Ordinary Shares · 50,001 shares

Expires 2031-01-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The shares vest in a series of 48 successive equal monthly installments beginning one month after January 22, 2021.

Read SEC document
June 12, 2024 Filed Jun 15, 2024 00:19 UTC
Stevens Raymond CDirector · CHIEF EXECUTIVE OFFICER
Exercise / conversionShare Option (right to buy) · Derivative 99,999 $0.00 Strike: $0.39 $0.00
Disclosure

SEC source: 0001415889-24-017040 · form4-06152024_120647.xml · derivative · entry 4

Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1

Underlying: Ordinary Shares · 99,999 shares

Expires 2030-01-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 12, 2024 Filed Jun 15, 2024 00:19 UTC
Stevens Raymond CDirector · CHIEF EXECUTIVE OFFICER
Exercise / conversionOrdinary Shares 50,001 $0.48 $24,000.48
Disclosure

SEC source: 0001415889-24-017040 · form4-06152024_120647.xml · nonDerivative · entry 2

Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 793,346

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 12, 2024 Filed Jun 15, 2024 00:19 UTC
Stevens Raymond CDirector · CHIEF EXECUTIVE OFFICER
Exercise / conversionOrdinary Shares 99,999 $0.39 $38,999.61
Disclosure

SEC source: 0001415889-24-017040 · form4-06152024_120647.xml · nonDerivative · entry 1

Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 743,345

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 10, 2024 Filed Jun 12, 2024 20:42 UTC
Stevens Raymond CDirector · CHIEF EXECUTIVE OFFICER
SaleAmerican Depositary Shares · Derivative 185,000 $52.80 $9,767,352.50
Disclosure

SEC source: 0001415889-24-016510 · form4-06122024_080615.xml · derivative · entry 4

Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 555,000 shares

Expires not disclosed

F3 · derivative.exercise_price: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date.

F4 · price: The weighted average sale price for the transaction was $52.7965, and the range of prices was $52.43 and $53.075. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

F3 · derivative.exercise_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date.

F3 · derivative.expiration_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date.

Read SEC document
June 10, 2024 Filed Jun 12, 2024 20:42 UTC
Stevens Raymond CDirector · CHIEF EXECUTIVE OFFICER
ConversionAmerican Depositary Shares · Derivative 185,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-016510 · form4-06122024_080615.xml · derivative · entry 3

Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 185,000

Underlying: Ordinary Shares · 555,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date.

F3 · derivative.exercise_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date.

F3 · derivative.expiration_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date.

Read SEC document
June 10, 2024 Filed Jun 12, 2024 20:42 UTC
Stevens Raymond CDirector · CHIEF EXECUTIVE OFFICER
ConversionOrdinary Shares 555,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-016510 · form4-06122024_080615.xml · nonDerivative · entry 1

Stevens Raymond C · CIK 0001698149 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 643,346

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The Ordinary Shares were converted into American Depositary Shares as reported in Table II above.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 23:38 UTC
Lin XichenCHIEF SCIENTIFIC OFFICER
SaleAmerican Depositary Shares · Derivative 17,700 $50.00 $885,070.80
Disclosure

SEC source: 0001415889-24-015683 · form4-06052024_110646.xml · derivative · entry 6

Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 53,100 shares

Expires not disclosed

F4 · derivative.exercise_price: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date.

F6 · shares: The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on December 28, 2023.

F7 · price: The weighted average sale price for the transaction reported was $50.004, and the range of prices were between $50.00 and $50.16. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

F4 · derivative.exercise_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date.

F4 · derivative.expiration_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 23:38 UTC
Lin XichenCHIEF SCIENTIFIC OFFICER
SaleAmerican Depositary Shares · Derivative 17,700 $45.00 $796,500.00
Disclosure

SEC source: 0001415889-24-015683 · form4-06052024_110646.xml · derivative · entry 5

Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,700

Underlying: Ordinary Shares · 53,100 shares

Expires not disclosed

F4 · derivative.exercise_price: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date.

F6 · shares: The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on December 28, 2023.

F4 · derivative.exercise_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date.

F4 · derivative.expiration_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 23:38 UTC
Lin XichenCHIEF SCIENTIFIC OFFICER
ConversionAmerican Depositary Shares · Derivative 35,400 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-015683 · form4-06052024_110646.xml · derivative · entry 4

Lin Xichen · CIK 0001962926 · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 35,400

Underlying: Ordinary Shares · 106,200 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date.

F5 · shares: 106,200 Ordinary Shares, which were acquired upon exercise of a share option, were converted into 35,400 American Depositary Shares.

F4 · derivative.exercise_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date.

F4 · derivative.expiration_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.